PANAKARE PLUS (PANCREATIC ENZYME) TABLET [NEOGEN CORPORATION-MERCER]

PANAKARE PLUS (PANCREATIC ENZYME) TABLET [NEOGEN CORPORATION-MERCER]
PDF | XML

NDC 59051-9067-5, 59051-9067-7
Set ID c9b7ae4f-3463-4054-9ad8-b75b0bd3b20f
Category PRESCRIPTION ANIMAL DRUG LABEL
Packager Neogen Corporation-Mercer
Generic Name
Product Class
Product Number
Application Number
  • PanaKare Plus Tablets

    Pancreatic Enzyme Concentrate

    CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • USE IN SPECIFIC POPULATIONS

    FOR ANIMAL USE ONLY

  • COMPONENTS

    Each tablet contains a minimum of:

    Lipase..............................9,000 USP units

    Protease.........................57,000 USP units

    Amylase..........................64,000 USP units

  • Description:

    PanaKare Plus is a pancreatic enzyme concentrate of porcine origin.

  • Precautions:

    Discontinue use in animals with symptoms of sensitivity or allergy.

  • SPL UNCLASSIFIED SECTION

    Made in the USA

  • WARNINGS

    KEEP OUT OF REACH OF CHILDREN

  • INDICATIONS & USAGE

    Indications:

    As a digestive aid in replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.

    Directions for use:

    Dose is administered before each meal. Estimate dose according to the severity of the condition and weight of the animal.

    Average dose/meal:

    Dogs: 2-3 tablets

    Cats: 1/2-1 tablet

  • STORAGE AND HANDLING

    Store tightly closed container in a dry place at temperatures not exceeding 35°C (95°F).

  • SPL UNCLASSIFIED SECTION

    Lot No.:

    Exp. Date:

    Manufactured by: Neogen Corporation

    Lexington, KY 40511 859-254-1221

    animalsafety.neogen.com

  • PRINCIPAL DISPLAY PANEL - 500 Tablet Bottle

    NDC: 59051-9067-7

    PanaKare Plus Tablets

    Pancreatic Enzyme Concentrate

    CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Net Contents: 500 Tablets

    L1731-1218

    Panakare Plus Tablets 500ct

  • PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle

    NDC: 59051-9067-5

    PanaKare Plus Tablets

    Pancreatic Enzyme Concentrate

    CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Net Contents: 100 Tablets

    L1730-1218

    Panakare Plus Tablets 100ct

  • INGREDIENTS AND APPEARANCE
    PANAKARE PLUS 
    pancreatic enzyme tablet
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:59051-9067
    Route of AdministrationOral
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PANCRELIPASE LIPASE (UNII: 8MYC33932O) (PANCRELIPASE LIPASE - UNII:8MYC33932O) PANCRELIPASE LIPASE9000 [iU]
    PANCRELIPASE AMYLASE (UNII: YOJ58O116E) (PANCRELIPASE AMYLASE - UNII:YOJ58O116E) PANCRELIPASE AMYLASE64000 [iU]
    PANCRELIPASE PROTEASE (UNII: 3560D81V50) (PANCRELIPASE PROTEASE - UNII:3560D81V50) PANCRELIPASE PROTEASE57000 [iU]
    Product Characteristics
    ColorbrownScoreno score
    ShapeROUNDSize11mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:59051-9067-7500 in 1 BOTTLE, PLASTIC
    2NDC:59051-9067-5100 in 1 BOTTLE, PLASTIC
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other05/15/2013
    Labeler - Neogen Corporation-Mercer (042125879)
    Establishment
    NameAddressID/FEIBusiness Operations
    Neogen Corporation-Mercer042125879analysis, label, manufacture

Related Drugs